Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4374
Title: | Recommendations for the evaluation of paediatric anisocoria: Utility of topical cocaine testing | Authors: | Shah, S. Dai, S. Li, Y. |
Issue Date: | 2022 | Source: | 49, (8), 2022, p. 940 | Pages: | 940 | Journal: | Clinical and Experimental Ophthalmology | Abstract: | Purpose: To propose recommendations for the evaluation of children with asymptomatic unilateral miosis, based on an evaluation of the outcomes of topical cocaine testing at the Queensland Children's Hospital, Australia, over the past four years. Methods: A retrospective review of children under the age of 16 tested using 5% topical cocaine. Data on demographic information, clinical findings, test outcomes, neuroimaging results, and the final diagnoses were collected. Results: Eighty-seven patients (median age six months, interquartile range = 13.25) were included. 69 (79.3%) patients presented with anisocoria only and 18 patients (20.7%) presented with anisocoria alongside ptosis and/or iris heterochromia (anisocoria plus). There were no cases of malignancy detected. Overall 13 (14.9%) children tested positive, 11 had idiopathic Horner syndrome, one had recent neck surgery and one had a traumatic birth. Children with anisocoria plus were more likely to have a positive cocaine test compared to anisocoria only (38.9% vs 8.7%, p < 0.01). 70 patients with a negative test had physiological anisocoria. 4 patients with an equivocal test were subsequently confirmed to have physiological anisocoria. Conclusions: In children, referrals for asymptomatic unilateral miosis are mostly physiological anisocoria. Isolated anisocoria does not require any further investigation. The cocaine test should be used as first line investigation for children with anisocoria plus other features of Horner syndrome. Children with a positive test should undergo neuroimaging and those with a negative test should have educational information on warning signs and clinical follow-up.L6366695282021-12-27 | DOI: | 10.1111/ceo.14014 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L636669528&from=exporthttp://dx.doi.org/10.1111/ceo.14014 | | Keywords: | conference abstract;controlled study;demography;female;follow up;Horner syndrome;human;iris;major clinical study;cocaineadolescent;malignant neoplasm;miosis;neck;neuroimaging;retrospective study;topical drug administration;male;anisocoria;birth injury;cancer patient;cancer surgery;child | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.